TABLE 3.
Follow-Up
| DG-HAL | HAL | P | |
|---|---|---|---|
| n = 76 | n = 46 | ||
| Follow-up (median, range) | 54 (6–86) | 32 (6–54) | <0.0001 |
| Recurrence | 18 (23.7) | 13 (28.3) | 0.574 |
| Prolapse | 8 (44.4) | 5 (38.5) | 0.739 |
| Bleeding | 1 (5.6) | 1 (7.7) | 1.000 |
| Prolapse and bleeding | 9 (50) | 7 (53.8) | 0.833 |
| Time to recurrence (median, range) | 18 (1–48) | 2 (1–24) | 0.135 |
| Grade of symptoms | |||
| Minor | 12 (66.7) | 7 (53.8) | 0.470 |
| Same | 5 (27.8) | 6 (46.2) | 0.449 |
| Greater | 1 (5.5) | 0 | 1.000 |
| Treatment of recurrence | |||
| No therapy | 7 (38.9) | 5 (38.5) | 0.981 |
| Medical therapy | 3 (16.7) | 6 (46.1) | 0.114 |
| Surgery | 8 (44.4) | 2 (15.4) | 0.129 |
| Satisfaction grade | |||
| Complete | 61 (80.3) | 30 (65.2) | 0.064 |
| Partial | 9 (11.8) | 9 (19.6) | 0.244 |
| Dissatisfaction | 6 (7.9) | 7 (15.2) | 0.235 |
Bold values indicate statistical significance.